TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza Therapy
New influenza therapy data have been reported by scientists at Westfalian Wilhelms University, Institute of Molecular Virology
November 11th, 2008
New research, 'Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy,' is the subject of a report. According to a study from Munster, Germany, "Influenza A virus remains a major public health concern, both in its annual toll in death and debilitation and its potential to cause devastating pandemics. Like any other virus, influenza A viruses are strongly dependent on cellular factors for replication." "One of the hallmark signaling factors activated by viral pathogens is the transcription factor NF-kappaB. Activation of NF-kappaB leads to the up-regulation of a variety of antiviral genes. Thus, the factor is commonly...
Source: TB & Outbreaks Week (2008-11-11)
|
